New guidelines for the diagnosis and management of acute pulmonary embolism (PE) have caught up with practice in that they now recommend a DOAC as the preferred form of anticoagulant treatment. The previous guidelines recommended DOACs as an alternative option to low molecular weight heparin (LMWH). The stronger 2019 recommendations for DOACs exclude patients with ...
Already a member?
Enter your email to keep reading.